Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
BackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in li...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841561069326172160 |
---|---|
author | XuWen Mao Guliruoyi Paerhati Yuche Wu Lu Feng Cheng |
author_facet | XuWen Mao Guliruoyi Paerhati Yuche Wu Lu Feng Cheng |
author_sort | XuWen Mao |
collection | DOAJ |
description | BackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in lipid distribution, inflammatory cytokines, glucose tolerance, gut microbiota composition, and serum metabolomics of 60 C57BL/6N mice.ResultsThe experimental results demonstrated that I3C reduced body weight, hepatic steatosis, and systemic inflammation and improved insulin resistance in mice on a high-fat diet (HFD). Furthermore, I3C remarkably enhanced the enrichment of probiotics Akkermansia and Ligilactobacillus as well as SCFA-producing bacteria (Eubacterium, Lactococcus, and Coprococcus), while reducing the abundance of Eisenbergiella and Rikenellaceae_RC9_gut_group. Also, I3C notably up-regulated the levels of Claudin4, Occludin, and ZO-1 proteins and modulated the metabolism of argininosuccinic acid and galactose.ConclusionThe aforementioned findings suggest that I3C exerts a significant anti-obesity effect in mice by regulating abnormal gut microbiome, enhancing intestinal barrier function, and improving metabolic disorders. |
format | Article |
id | doaj-art-d964b7d9edc74a0aaaac8ed0f6c8bda9 |
institution | Kabale University |
issn | 1663-9812 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj-art-d964b7d9edc74a0aaaac8ed0f6c8bda92025-01-03T06:47:24ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14991421499142Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in miceXuWen Mao0Guliruoyi Paerhati1Yuche Wu2Lu Feng Cheng3College of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaCollege of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaXinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (CAS), Ürümqi, ChinaCollege of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaBackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in lipid distribution, inflammatory cytokines, glucose tolerance, gut microbiota composition, and serum metabolomics of 60 C57BL/6N mice.ResultsThe experimental results demonstrated that I3C reduced body weight, hepatic steatosis, and systemic inflammation and improved insulin resistance in mice on a high-fat diet (HFD). Furthermore, I3C remarkably enhanced the enrichment of probiotics Akkermansia and Ligilactobacillus as well as SCFA-producing bacteria (Eubacterium, Lactococcus, and Coprococcus), while reducing the abundance of Eisenbergiella and Rikenellaceae_RC9_gut_group. Also, I3C notably up-regulated the levels of Claudin4, Occludin, and ZO-1 proteins and modulated the metabolism of argininosuccinic acid and galactose.ConclusionThe aforementioned findings suggest that I3C exerts a significant anti-obesity effect in mice by regulating abnormal gut microbiome, enhancing intestinal barrier function, and improving metabolic disorders.https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/fullindole-3-carbinolgut microantha biotaobesityserum metabolomicsZO-1 |
spellingShingle | XuWen Mao Guliruoyi Paerhati Yuche Wu Lu Feng Cheng Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice Frontiers in Pharmacology indole-3-carbinol gut microantha biota obesity serum metabolomics ZO-1 |
title | Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice |
title_full | Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice |
title_fullStr | Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice |
title_full_unstemmed | Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice |
title_short | Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice |
title_sort | modulation of gut microbiota up regulation of zo 1 and promotion of metabolism as therapeutic mechanisms of indole 3 carbinol against obesity in mice |
topic | indole-3-carbinol gut microantha biota obesity serum metabolomics ZO-1 |
url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/full |
work_keys_str_mv | AT xuwenmao modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice AT guliruoyipaerhati modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice AT yuchewu modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice AT lufengcheng modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice |